Literature DB >> 9789338

Risk of decompression sickness with patent foramen ovale.

A A Bove1.   

Abstract

Several reports have described populations of divers with decompression sickness (DCS) who have a patent foramen ovale (PFO). The presence of a PFO is known to occur in about 30% of the normal population, hence 30% of divers are likely to have a PFO. Although observations have been made on the presence of a PFO in divers with and without DCS, the risk of developing DCS when a diver has a PFO has not been determined. In this study, Logistic Regression and Bayes' theorem were used to calculate the risk of DCS from data of three studies that reported on echocardiographic analysis of PFO in a diving population, some of whom developed DCS. Overall incidence of DCS was obtained from the sport diving population, from the U.S. Navy diving population, and from a commercial population. The analysis indicates that the presence of a PFO produces a 2.5 time increase in the odds ratio for developing serious (type II) DCS in all three types of divers. Since the incidence of type II DCS in these three populations averages 2.28/10,000 dives, the risk of developing DCS in the presence of a PFO remains small, and does not warrant routine screening by echocardiography of sport, military, or commercial divers.

Entities:  

Mesh:

Year:  1998        PMID: 9789338

Source DB:  PubMed          Journal:  Undersea Hyperb Med        ISSN: 1066-2936            Impact factor:   0.698


  13 in total

Review 1.  The physiological kinetics of nitrogen and the prevention of decompression sickness.

Authors:  D J Doolette; S J Mitchell
Journal:  Clin Pharmacokinet       Date:  2001-01       Impact factor: 6.447

2.  The effectiveness of risk mitigation interventions in divers with persistent (patent) foramen ovale.

Authors:  George Anderson; Douglas Ebersole; Derek Covington; Petar J Denoble
Journal:  Diving Hyperb Med       Date:  2019-06-30       Impact factor: 0.887

Review 3.  Neuroimaging of diving-related decompression illness: current knowledge and perspectives.

Authors:  J Kamtchum Tatuene; R Pignel; P Pollak; K O Lovblad; A Kleinschmidt; M I Vargas
Journal:  AJNR Am J Neuroradiol       Date:  2014-06-12       Impact factor: 3.825

Review 4.  The management of patent foramen ovale in divers: where do we stand?

Authors:  Anastasios Apostolos; Maria Drakopoulou; George Trantalis; Αndreas Synetos; George Oikonomou; Theodoros Karapanayiotides; Costas Tsioufis; Konstantinos Toutouzas
Journal:  Ther Adv Neurol Disord       Date:  2022-07-09       Impact factor: 6.430

Review 5.  Headache and facial pain in scuba divers.

Authors:  William P Cheshire
Journal:  Curr Pain Headache Rep       Date:  2004-08

6.  Does persistent (patent) foramen ovale closure reduce the risk of recurrent decompression sickness in scuba divers?

Authors:  Björn Edvinsson; Ulf Thilén; Niels Erik Nielsen; Christina Christersson; Mikael Dellborg; Peter Eriksson; Joanna Hlebowicz
Journal:  Diving Hyperb Med       Date:  2021-03-31       Impact factor: 0.887

Review 7.  A review of diving practices and outcomes following the diagnosis of a persistent (patent) foramen ovale in compressed air divers with a documented episode of decompression sickness.

Authors:  Christopher W Scarff; John Lippmann; Andrew Fock
Journal:  Diving Hyperb Med       Date:  2020-12-20       Impact factor: 0.887

8.  The incidence of peripheral arterial embolism in association with a patent foramen ovale (right-to-left shunt).

Authors:  Yusuf Ali Kausar Rushdi; Hina Hina; Bijendra Patel; Frank W Cross
Journal:  JRSM Short Rep       Date:  2011-05-03

9.  Otorhinolaryngologic disorders and diving accidents: an analysis of 306 divers.

Authors:  Christoph Klingmann; Mark Praetorius; Ingo Baumann; Peter K Plinkert
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-07-17       Impact factor: 3.236

10.  Magnetic resonance imaging in breath-hold divers with cerebral decompression sickness.

Authors:  Ryu Matsuo; Masahiro Kamouchi; Shuji Arakawa; Yoshihiko Furuta; Yuka Kanazawa; Takanari Kitazono
Journal:  Case Rep Neurol       Date:  2014-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.